CYSTM1 is a potential diagnostic and prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma - Zhang, Ning; Zhen, Junling; Kong, Xiangnan (Journal of Gastrointestinal Oncology; Vol 16, No 5 (October 31, 2025): Journal of Gastrointestinal Oncology, 2025)